Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and Desensitization
Conditions: Lung Transplant Rejection; Antibody-mediated Rejection Interventions: Drug: Belatacept; Drug: Carfilzomib Sponsors: Duke University; Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials